Hypercalcemia Malignancy Factor (1-34), human corresponds to an N-terminal fragment structurally related to parathyroid hormone-related sequences. The peptide forms helical structures that can be probed by spectroscopic methods. Its residue pattern supports detailed mapping of interaction motifs. Applications include structural biology, peptide engineering, and ligand-receptor interface studies.
CAT No: P03057
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More